Illumina NovaSeq 6000 paired end sequencing; Pseudomonas aeruginosa PA14 exposed to the aminothiol cysteamine during growth in synthetic cystic fibrosis sputum media (SCFM2)

ERR5671634 E-MTAB-10326:SLX-20067.A3.H33T7DRXY.s_1.r_ Illumina NovaSeq 6000 paired end sequencing; Pseudomonas aeruginosa PA14 exposed to the aminothiol cysteamine during growth in synthetic cystic fibrosis sputum media (SCFM2) ERX5387121 ENA-FIRST-PUBLIC 2021-11-01 ENA-LAST-UPDATE 2021-11-01 ERR5671635 E-MTAB-10326:SLX-20067.A3.H33T7DRXY.s_2.r_ Illumina NovaSeq 6000 paired end sequencing; Pseudomonas aeruginosa PA14 exposed to the aminothiol cysteamine during growth in synthetic cystic fibrosis sputum media (SCFM2) ERX5387121 ENA-FIRST-PUBLIC 2021-11-01 ENA-LAST-UPDATE 2021-11-01 ERR5671636 E-MTAB-10326:SLX-20067.B3.H33T7DRXY.s_1.r_ Illumina NovaSeq 6000 paired end sequencing; Pseudomonas aeruginosa PA14 exposed to the aminothiol cysteamine during growth in synthetic cystic fibrosis sputum media (SCFM2) ERX5387122 ENA-FIRST-PUBLIC 2021-11-01 ENA-LAST-UPDATE 2021-11-01 ERR5671637 E-MTAB-10326:SLX-20067.B3.H33T7DRXY.s_2.r_ Illumina NovaSeq 6000 paired end sequencing; Pseudomonas aeruginosa PA14 exposed to the aminothiol cysteamine during growth in synthetic cystic fibrosis sputum media (SCFM2) ERX5387122 ENA-FIRST-PUBLIC 2021-11-01 ENA-LAST-UPDATE 2021-11-01 ERR5671638 E-MTAB-10326:SLX-20067.C3.H33T7DRXY.s_1.r_ Illumina NovaSeq 6000 paired end sequencing; Pseudomonas aeruginosa PA14 exposed to the aminothiol cysteamine during growth in synthetic cystic fibrosis sputum media (SCFM2) ERX5387123 ENA-FIRST-PUBLIC 2021-11-01 ENA-LAST-UPDATE 2021-11-01 ERR5671639 E-MTAB-10326:SLX-20067.C3.H33T7DRXY.s_2.r_ Illumina NovaSeq 6000 paired end sequencing; Pseudomonas aeruginosa PA14 exposed to the aminothiol cysteamine during growth in synthetic cystic fibrosis sputum media (SCFM2) ERX5387123 ENA-FIRST-PUBLIC 2021-11-01 ENA-LAST-UPDATE 2021-11-01 ERR5671640 E-MTAB-10326:SLX-20067.D3.H33T7DRXY.s_1.r_ Illumina NovaSeq 6000 paired end sequencing; Pseudomonas aeruginosa PA14 exposed to the aminothiol cysteamine during growth in synthetic cystic fibrosis sputum media (SCFM2) ERX5387124 ENA-FIRST-PUBLIC 2021-11-01 ENA-LAST-UPDATE 2021-11-01 ERR5671641 E-MTAB-10326:SLX-20067.D3.H33T7DRXY.s_2.r_ Illumina NovaSeq 6000 paired end sequencing; Pseudomonas aeruginosa PA14 exposed to the aminothiol cysteamine during growth in synthetic cystic fibrosis sputum media (SCFM2) ERX5387124 ENA-FIRST-PUBLIC 2021-11-01 ENA-LAST-UPDATE 2021-11-01 ERR5671642 E-MTAB-10326:SLX-20067.E3.H33T7DRXY.s_1.r_ Illumina NovaSeq 6000 paired end sequencing; Pseudomonas aeruginosa PA14 exposed to the aminothiol cysteamine during growth in synthetic cystic fibrosis sputum media (SCFM2) ERX5387125 ENA-FIRST-PUBLIC 2021-11-01 ENA-LAST-UPDATE 2021-11-01 ERR5671643 E-MTAB-10326:SLX-20067.E3.H33T7DRXY.s_2.r_ Illumina NovaSeq 6000 paired end sequencing; Pseudomonas aeruginosa PA14 exposed to the aminothiol cysteamine during growth in synthetic cystic fibrosis sputum media (SCFM2) ERX5387125 ENA-FIRST-PUBLIC 2021-11-01 ENA-LAST-UPDATE 2021-11-01 ERR5671644 E-MTAB-10326:SLX-20067.F3.H33T7DRXY.s_1.r_ Illumina NovaSeq 6000 paired end sequencing; Pseudomonas aeruginosa PA14 exposed to the aminothiol cysteamine during growth in synthetic cystic fibrosis sputum media (SCFM2) ERX5387126 ENA-FIRST-PUBLIC 2021-11-01 ENA-LAST-UPDATE 2021-11-01 ERR5671645 E-MTAB-10326:SLX-20067.F3.H33T7DRXY.s_2.r_ Illumina NovaSeq 6000 paired end sequencing; Pseudomonas aeruginosa PA14 exposed to the aminothiol cysteamine during growth in synthetic cystic fibrosis sputum media (SCFM2) ERX5387126 ENA-FIRST-PUBLIC 2021-11-01 ENA-LAST-UPDATE 2021-11-01